ALDH7A1 and Epileptic encephalopathy: Before the confirmation of PDE by biochemical and/or genetic methods, difficult clinical diagnosis resulted in a prevalence that varied from 1∶20.000 to 1∶600.000 infants with epileptic encephalopathy in the UK [14]–[16].